930 related articles for article (PubMed ID: 21324198)
21. Soluble urokinase-type plasminogen activator receptor levels in patients with burn injuries and inhalation trauma requiring mechanical ventilation: an observational cohort study.
Backes Y; van der Sluijs KF; Tuip de Boer AM; Hofstra JJ; Vlaar AP; Determann RM; Knape P; Mackie DP; Schultz MJ
Crit Care; 2011; 15(6):R270. PubMed ID: 22085408
[TBL] [Abstract][Full Text] [Related]
22. Persistently elevated osteopontin serum levels predict mortality in critically ill patients.
Roderburg C; Benz F; Cardenas DV; Lutz M; Hippe HJ; Luedde T; Trautwein C; Frey N; Koch A; Tacke F; Luedde M
Crit Care; 2015 Jun; 19(1):271. PubMed ID: 26111529
[TBL] [Abstract][Full Text] [Related]
23. Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis.
Savva A; Raftogiannis M; Baziaka F; Routsi C; Antonopoulou A; Koutoukas P; Tsaganos T; Kotanidou A; Apostolidou E; Giamarellos-Bourboulis EJ; Dimopoulos G
J Infect; 2011 Nov; 63(5):344-50. PubMed ID: 21839112
[TBL] [Abstract][Full Text] [Related]
24. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
25. Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis.
Zeng M; Chang M; Zheng H; Li B; Chen Y; He W; Huang C
Am J Emerg Med; 2016 Mar; 34(3):375-80. PubMed ID: 26615223
[TBL] [Abstract][Full Text] [Related]
26. Relevance of serum sclerostin concentrations in critically ill patients.
Koch A; Weiskirchen R; Ludwig S; Buendgens L; Bruensing J; Yagmur E; Baeck C; Herbers U; Trautwein C; Tacke F
J Crit Care; 2017 Feb; 37():38-44. PubMed ID: 27621111
[TBL] [Abstract][Full Text] [Related]
27. Thrombo-inflammatory biomarkers to predict sepsis outcome.
Efat A; Shoeib SA; Arafa AF; Dawod AA; Abd ElHafez MA; Abd ElMohsen EA; Eladly HF; Ibrahim RA; Elkholy A
Int J Immunopathol Pharmacol; 2021; 35():20587384211048561. PubMed ID: 34647483
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the Mortality Prediction Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in COVID-19 and Sepsis.
Vassiliou AG; Zacharis A; Vrettou CS; Keskinidou C; Jahaj E; Mastora Z; Orfanos SE; Dimopoulou I; Kotanidou A
Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626416
[TBL] [Abstract][Full Text] [Related]
29. Soluble Urokinase Receptor and Acute Kidney Injury.
Hayek SS; Leaf DE; Samman Tahhan A; Raad M; Sharma S; Waikar SS; Sever S; Camacho A; Wang X; Dande RR; Ibrahim NE; Baron RM; Altintas MM; Wei C; Sheikh-Hamad D; Pan JS; Holliday MW; Januzzi JL; Weisbord SD; Quyyumi AA; Reiser J
N Engl J Med; 2020 Jan; 382(5):416-426. PubMed ID: 31995687
[TBL] [Abstract][Full Text] [Related]
30. Soluble urokinase plasminogen activator receptor (suPAR) in children with obesity or type 1 diabetes as a marker of endothelial dysfunction: a cross-sectional study.
Kostopoulou E; Kalavrizioti D; Davoulou P; Sinopidis X; Papachristou E; Goumenos DS; Dimitriou G; Spiliotis BE; Papasotiriou M
Eur J Pediatr; 2024 May; 183(5):2383-2389. PubMed ID: 38448612
[TBL] [Abstract][Full Text] [Related]
31. Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure.
Koch A; Zimmermann HW; Gassler N; Jochum C; Weiskirchen R; Bruensing J; Buendgens L; Dückers H; Bruns T; Gerken G; Neumann UP; Adams DH; Trautwein C; Canbay A; Tacke F
Liver Int; 2014 Oct; 34(9):1330-9. PubMed ID: 24575897
[TBL] [Abstract][Full Text] [Related]
32. Soluble urokinase-type plasminogen activator receptor in patients with suspected infection in the emergency room: a prospective cohort study.
Uusitalo-Seppälä R; Huttunen R; Tarkka M; Aittoniemi J; Koskinen P; Leino A; Vahlberg T; Rintala EM
J Intern Med; 2012 Sep; 272(3):247-56. PubMed ID: 22755554
[TBL] [Abstract][Full Text] [Related]
33. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome.
Raggam RB; Wagner J; Prüller F; Grisold A; Leitner E; Zollner-Schwetz I; Valentin T; Krause R; Hoenigl M
J Intern Med; 2014 Dec; 276(6):651-8. PubMed ID: 24645798
[TBL] [Abstract][Full Text] [Related]
34. Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor.
Giamarellos-Bourboulis EJ; Norrby-Teglund A; Mylona V; Savva A; Tsangaris I; Dimopoulou I; Mouktaroudi M; Raftogiannis M; Georgitsi M; Linnér A; Adamis G; Antonopoulou A; Apostolidou E; Chrisofos M; Katsenos C; Koutelidakis I; Kotzampassi K; Koratzanis G; Koupetori M; Kritselis I; Lymberopoulou K; Mandragos K; Marioli A; Sundén-Cullberg J; Mega A; Prekates A; Routsi C; Gogos C; Treutiger CJ; Armaganidis A; Dimopoulos G
Crit Care; 2012 Aug; 16(4):R149. PubMed ID: 22873681
[TBL] [Abstract][Full Text] [Related]
35. SuPAR and PAI-1 in critically ill, mechanically ventilated patients.
Jalkanen V; Yang R; Linko R; Huhtala H; Okkonen M; Varpula T; Pettilä V; Tenhunen J;
Intensive Care Med; 2013 Mar; 39(3):489-96. PubMed ID: 23100007
[TBL] [Abstract][Full Text] [Related]
36. suPAR as a prognostic biomarker in sepsis.
Donadello K; Scolletta S; Covajes C; Vincent JL
BMC Med; 2012 Jan; 10():2. PubMed ID: 22221662
[TBL] [Abstract][Full Text] [Related]
37. Regulation and prognostic relevance of symmetric dimethylarginine serum concentrations in critical illness and sepsis.
Koch A; Weiskirchen R; Bruensing J; Dückers H; Buendgens L; Kunze J; Matthes M; Luedde T; Trautwein C; Tacke F
Mediators Inflamm; 2013; 2013():413826. PubMed ID: 23935249
[TBL] [Abstract][Full Text] [Related]
38. Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality.
Zimmermann HW; Reuken PA; Koch A; Bartneck M; Adams DH; Trautwein C; Stallmach A; Tacke F; Bruns T
J Intern Med; 2013 Jul; 274(1):86-100. PubMed ID: 23432143
[TBL] [Abstract][Full Text] [Related]
39. Serum Levels of Soluble Urokinase Plasminogen Activator Receptor in Infants with Late-onset Sepsis.
Okulu E; Arsan S; Akin IM; Ates C; Alan S; Kilic A; Atasay B
J Clin Lab Anal; 2015 Sep; 29(5):347-52. PubMed ID: 25043869
[TBL] [Abstract][Full Text] [Related]
40. Why high suPAR is not super--diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU.
Koch A; Tacke F
Crit Care; 2011; 15(6):1020. PubMed ID: 22182777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
